Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency (original) (raw)

References

  1. Roberts, A.B. & Sporn, M.B. in: Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors Vol 95/I (eds. Sporn, M.B. & Roberts, A.B) 419–472 (Springer-Verlag, Berlin, 1990).
    Book Google Scholar
  2. Sporn, M.B. & Roberts, A.B. Autocrine growth factors and cancer. Nature 313, 745–747 (1985).
    Article CAS PubMed Google Scholar
  3. Fynan, T.M. & Reiss, M. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit. Rev. Oncog. 4, 493–540 (1993).
    CAS PubMed Google Scholar
  4. Brattain, M.C., Markowitz, S.D. & Willson, J.K. The type II transforming growth factor-β1 receptor as a tumor-suppressor gene. Curr. Opin. Oncol. 8, 49–53 (1996).
    Article CAS PubMed Google Scholar
  5. Markowitz, S. et al. Inactivation of the type II TGF-β receptor in colon cancer cells with micrasatellite instability. Science 268, 1336–1338 (1995).
    Article CAS PubMed Google Scholar
  6. Hahn, S.A. et al. DPC4, a candidate tumor suppressor gene at human chromosomel 8q21.1. Science 271, 350–353 (1996).
    Article CAS PubMed Google Scholar
  7. De Souza, A.T., Hankins, C.R., Washington, M.K., Orton, T.C. & Jirtle, R.L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genet. 11, 447–149 (1995).
    Article CAS PubMed Google Scholar
  8. Wu, S.P. et al. TCF-β1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol. 116, 187–196 (1992).
    Article CAS PubMed Google Scholar
  9. Huang, F., Newman, E., Theodorescu, D., Kerbel, R.S. & Friedman, E. Transforming growth factor β1 (TGFβ1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF-β1 antisense expression plasmid. Cell Growth Differ. 6, 1635–1642 (1995).
    CAS PubMed Google Scholar
  10. Corsch, S.M., Memoli, V.A., Stukel, T.A., Gold, L.I. & Arrick, B.A. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res, 52, 6949–6952 (1992).
    Google Scholar
  11. Tsushima, H. et al. High levels of transforming growth factor β1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110, 375–382 (1996).
    Article CAS PubMed Google Scholar
  12. Fearon, E.R. Human cancer syndromes: clues to the origin and nature of cancer. Science 278, 1043–1050 (1997).
    Article CAS PubMed Google Scholar
  13. Kulkami, A.B. et al. Transforming growth factor (11 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA, 90, 770–774 (1993).
    Article Google Scholar
  14. Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693–699 (1992).
    Article CAS PubMed PubMed Central Google Scholar
  15. Carr, B.I., Hayashi, I., Branum, E.L. & Moses, H.L. Inhibition of DNA synthesis in rat hepatocytes by platelet- derived type p transforming growth factor. Cancer Res. 46, 2330–2334 (1986).
    CAS PubMed Google Scholar
  16. Russell, W.E., Coffey, R.J.Jr., Ouellette, A.J. & Moses, H.L. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 85, 5126–5130 (1988).
    Article CAS PubMed PubMed Central Google Scholar
  17. Oberhammer, F.A. et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA, 89, 5408–5412(1992).
  18. Evan, G.I. et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119–128 (1992).
    Article CAS PubMed Google Scholar
  19. Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).
    Article CAS PubMed Google Scholar
  20. Naik, P., Karrim, J. & Hanahan, D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10, 2105–2116 (1996).
    Article CAS PubMed Google Scholar
  21. Crocker, T.T., Teeter, A. & Nielsen, B. Postnatal cellular proliferation in mouse and hamster lung. Cancer Res. 30, 357–361 (1970).
    CAS PubMed Google Scholar
  22. Ravitz, M.J. & Wenner, C.E. Cyclin-dependent kinase regulation during Gl phase and cell cycle regulation by TGF-β. Adv. Cancer Res. 71, 165–207 (1997).
    Article CAS PubMed Google Scholar
  23. lavarone, A. & Massague, J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387, 417–422 (1997)
    Article Google Scholar
  24. Border, W.A. & Ruoslahti, E. Transforming growth factor-β in disease: the dark side of tissue repair. J. Clin. Invest. 90, 1–7 (1992).
    Article CAS PubMed PubMed Central Google Scholar
  25. Nathan, C. & Sporn, M. Cytokines in Context. J. Cell Biol. 113:5, 981–986 (1991).
    Article CAS PubMed Google Scholar
  26. Diwan, B.A., Rice, J.M., Ward, J.M., Ohshima, M. & Lynch, P.H. Inhibition by phenobarbital and lack of effect of amobarbital on the development of liver tumors induced by N-Nitrosodiethylamine in juvenile B6C3F1 mice. Cancer Lett. 23, 223–234 (1984).
    Article CAS PubMed Google Scholar
  27. Glick, A.B. et al. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA, 90, 6076–6080 (1993).
    Article CAS PubMed PubMed Central Google Scholar
  28. Click, A.B. et al. Targeted deletion of the TCF-β1 gene causes rapid progression to squamous cell carcinoma. Genes Dev. 8, 2429–2440 (1994).
    Article Google Scholar
  29. Glick, A.B., Weinberg, W.C., Wu, I.-H., Quan, W. & Yuspa, S.H. Transforming growth factor β1 suppresses genomic instability independent of a C, arrest, p53 and Rb. Cancer Res. 56, 3645–3650 (1996).
    CAS PubMed Google Scholar
  30. Cui, W. et al. TCF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531–542 (1996).
    Article CAS PubMed Google Scholar
  31. Torre-Amione, C. et al. A highly immunogenic tumor transfected with a murine transforming growth factor type β1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA, 87, 1486–1490 (1990).
    Article CAS PubMed PubMed Central Google Scholar
  32. Fajardo, L.F., Prionas, S.D., Kwan, H.H., Kowalski, J. & Allison, A.C. Transforming growth factor β1 induces angiogenesis in vivo with a threshold pattern. Lab. Invest. 74, 600–608 (1996).
    CAS PubMed Google Scholar
  33. Markowitz, S.D. & Roberts, A.B. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7, 93–102 (1996).
    Article CAS PubMed Google Scholar
  34. Bottinger, E.P., Jakubczak, J.L., Haines, D.C., Bagnall, K. & Wakefield, L.M. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and iung in response to the carcinogen 7,12-dimethylbenz-[a]-anthrancene. Cancer Res. 57, 5564–5570 (1997).
    CAS PubMed Google Scholar
  35. Maroulakou, I.G., Anver, M., Garett, L., & Green, J.E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl. Acad. Sci. USA, 91, 11236–11240 (1994).
    Article CAS PubMed PubMed Central Google Scholar
  36. Tashiro, H. et al. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron. Artery Dis. 8, 143–147 (1997).
    Article CAS PubMed Google Scholar
  37. Cambien, F. et al. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de I'lnfarctus du Myocarde (ECTIM) Study. Hypertension, 28, 881–887 (1996).
    Article CAS PubMed Google Scholar
  38. Langdahl, B.L., Knudsen, |.Y., lensen, H.K., Gregersen, N. & Eriksen, E.F. A sequence variation: 713-8delC in the transforming growth factor-β1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20, 289–294 (1997).
    Article CAS PubMed Google Scholar
  39. Firth, C.H., Ward, J.M & Turuson, V.S. in Pathology of Tumors in Laboratory Animals. Vol.2. Tumours of the Mouse, 2nd edn. (eds. V. Turosoy & U. Mohr) 223–269 (IARC Scientific Publications, 1984).
    Google Scholar
  40. Rehm, S., Werd, J.M. & Sabs, B. in Pathology of Tumors in Laboratory Animals. Vol.2. Tumours of the Mouse, 2nd edn. (eds. V. Turosov & U. Mohr) 325–355 (IARC Publications, Lyon, France, 1984)
    Google Scholar
  41. Danielpour, D. & Roberts, A.B. Specific and sensitive quantitation of transforming growth factor P3 by sandwich enzyme-linked immunosorbent assay. J. Immunol. Methods, 180, 265–272 (1995).
    Article CAS PubMed Google Scholar
  42. Danielpour, D. et al. Sandwich enzyme-linked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-β (TGF-β1 and TGF-β2) in complex biological fluids. Growth Factors, 2, 61–71 (1989).
    Article CAS PubMed Google Scholar
  43. Church, G.M. & Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81, 1991–1995 (1984).
    Article CAS PubMed PubMed Central Google Scholar
  44. Jakowlew, S.B., Moody, T.W., You, L. & Mariano, J.M. Reduction of transforming growth factor-β type II receptor in mouse lung carcinogenesis. Mol. Carcinog. 22, 46–56 (1998).
    Article CAS PubMed Google Scholar
  45. Flanders, K.C. et al. Transforming growth factor-β1: histochemical localization with antibodies to different epitopes. J. Cell Biol. 108, 653–660 (1989).
    Article CAS PubMed Google Scholar

Download references